Your browser is no longer supported. Please, upgrade your browser.
COLL Collegium Pharmaceutical, Inc. monthly Stock Chart
Collegium Pharmaceutical, Inc.
Index- P/E- EPS (ttm)-0.01 Insider Own2.20% Shs Outstand34.40M Perf Week-4.61%
Market Cap613.80M Forward P/E11.39 EPS next Y1.58 Insider Trans-15.52% Shs Float32.14M Perf Month-9.46%
Income0.20M PEG- EPS next Q0.22 Inst Own- Short Float13.62% Perf Quarter10.91%
Sales301.70M P/S2.03 EPS this Y42.80% Inst Trans0.51% Short Ratio13.21 Perf Half Y-12.96%
Book/sh4.53 P/B3.97 EPS next Y115.26% ROA0.00% Target Price28.00 Perf Year51.39%
Cash/sh4.27 P/C4.21 EPS next 5Y0.55% ROE0.20% 52W Range11.52 - 25.59 Perf YTD-12.54%
Dividend- P/FCF11.16 EPS past 5Y5.70% ROI-24.00% 52W High-29.50% Beta1.17
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin46.00% 52W Low56.60% ATR0.90
Employees255 Current Ratio1.00 Sales Q/Q4.10% Oper. Margin4.30% RSI (14)35.82 Volatility4.59% 4.38%
OptionableYes Debt/Eq1.78 EPS Q/Q262.80% Profit Margin0.10% Rel Volume0.84 Prev Close18.00
ShortableYes LT Debt/Eq1.48 EarningsNov 05 AMC Payout- Avg Volume331.49K Price18.04
Recom2.10 SMA20-11.87% SMA50-7.47% SMA200-6.99% Volume278,989 Change0.22%
Jul-14-20Initiated BWS Financial Sell $8
May-27-20Initiated Guggenheim Neutral
Feb-19-20Resumed Jefferies Buy $43
Oct-30-19Reiterated Needham Buy $33 → $25
May-03-19Resumed H.C. Wainwright Buy $23
Apr-12-19Resumed Janney Buy $29
Mar-20-19Initiated SunTrust Hold $22
Jan-16-19Reiterated Needham Buy $35 → $33
Mar-08-18Reiterated H.C. Wainwright Buy $21 → $33
Feb-07-18Reiterated Needham Buy $28 → $35
Dec-05-17Reiterated Needham Buy $25 → $28
Sep-11-17Initiated H.C. Wainwright Buy $21
May-11-17Reiterated Needham Buy $28 → $25
Sep-13-16Initiated Gabelli & Co Buy $25
Jun-01-15Initiated Piper Jaffray Overweight $26
Jun-01-15Initiated Needham Buy $28
Jun-01-15Initiated Jefferies Buy $20
Oct-29-20 12:35PM  
Oct-26-20 08:00AM  
Oct-25-20 07:05AM  
Oct-22-20 04:01PM  
Oct-12-20 01:25PM  
Oct-04-20 06:51AM  
Sep-30-20 08:00AM  
Sep-25-20 08:00AM  
Sep-14-20 08:00AM  
Sep-09-20 04:05PM  
Aug-07-20 11:39AM  
Aug-05-20 07:15PM  
Aug-04-20 12:04PM  
Aug-03-20 12:59PM  
Jul-29-20 12:33PM  
Jul-21-20 05:00PM  
Jul-07-20 11:40AM  
Jun-19-20 11:40AM  
Jun-17-20 05:09PM  
Jun-03-20 11:40AM  
May-27-20 08:44AM  
May-18-20 11:40AM  
May-13-20 11:06AM  
May-08-20 12:31PM  
May-07-20 04:01PM  
Apr-30-20 12:34PM  
Apr-23-20 04:01PM  
Apr-07-20 04:01PM  
Apr-06-20 09:30AM  
Apr-01-20 08:50AM  
Mar-26-20 11:40AM  
Mar-24-20 05:03AM  
Mar-20-20 07:44AM  
Mar-10-20 11:40AM  
Feb-27-20 04:01PM  
Feb-26-20 01:05PM  
Feb-20-20 12:31PM  
Feb-13-20 04:01PM  
Feb-10-20 07:15PM  
Feb-08-20 07:04AM  
Feb-07-20 07:32AM  
Feb-06-20 04:01PM  
Jan-31-20 05:00PM  
Jan-21-20 08:41AM  
Jan-14-20 11:50AM  
Jan-09-20 08:39AM  
Jan-08-20 08:12AM  
Jan-07-20 04:05PM  
Dec-13-19 11:32AM  
Dec-10-19 05:43PM  
Dec-06-19 02:39PM  
Nov-26-19 08:01AM  
Nov-08-19 08:14AM  
Nov-06-19 06:25PM  
Oct-30-19 10:34AM  
Oct-23-19 08:00AM  
Oct-19-19 10:02AM  
Sep-26-19 04:08PM  
Sep-25-19 08:00AM  
Sep-23-19 06:00AM  
Sep-03-19 04:01PM  
Aug-29-19 04:01PM  
Aug-08-19 11:24PM  
Aug-07-19 06:35PM  
Jul-31-19 10:36AM  
Jul-24-19 04:01PM  
Jul-23-19 12:19PM  
Jun-28-19 05:03PM  
Jun-19-19 10:41AM  
May-29-19 08:00AM  
May-09-19 10:03PM  
May-08-19 05:45PM  
May-06-19 11:54AM  
May-05-19 09:19AM  
May-01-19 10:33AM  
Apr-30-19 04:01PM  
Apr-24-19 04:01PM  
Apr-02-19 08:00AM  
Apr-01-19 08:00AM  
Mar-31-19 09:45AM  
Mar-25-19 09:00AM  
Mar-06-19 11:49PM  
Mar-04-19 01:46AM  
Feb-27-19 07:14PM  
Feb-20-19 10:31AM  
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes various products for patients suffering from pain. It provides DETERx platform technology that is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods of abuse and misuse, including chewing, crushing, and injecting. The company also offers Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for opioid medication. In addition, it offers Nucynta ER, an extended release formulation of tapentadol for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment, such as neuropathic pain related to diabetic peripheral neuropathy in adults; and Nucynta IR, an immediate release formulation of tapentadol that is indicated for the management of moderate to severe acute pain in adults. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kuhlmann Shirley R.EVP and General CounselOct 15Sale20.827,060146,98957,531Oct 16 04:07 PM
Heffernan Michael ThomasDirectorAug 11Sale19.1313,071250,04854,122Aug 12 04:05 PM
Dreyer ScottEVP & Chief Commercial OfficerJul 13Sale17.011,42924,30746,418Jul 14 04:06 PM
Ciaffoni JosephPresident and CEOJun 02Sale20.485,861120,058192,798Jun 02 06:58 PM
Ciaffoni JosephPresident and CEOJun 01Option Exercise8.2264,820532,820269,335Jun 02 06:58 PM
Ciaffoni JosephPresident and CEOJun 01Sale21.5370,6761,521,709198,659Jun 02 06:58 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 18Option Exercise15.908,000127,20056,441May 20 04:18 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 18Sale24.008,000192,00048,441May 20 04:18 PM
Fleming Alison BChief Technology OfficerMay 13Sale21.677,989173,147102,901May 15 04:16 PM
Heffernan Michael ThomasDirectorMay 13Sale21.6319,254416,42181,796May 15 04:17 PM
Dreyer ScottEVP & Chief Commercial OfficerMay 13Sale22.614,434100,25348,441May 15 04:15 PM
Heffernan Michael ThomasDirectorJan 21Option Exercise5.73275,4631,578,403402,086Jan 22 04:29 PM
Heffernan Michael ThomasDirectorJan 21Sale21.93295,2876,476,863106,799Jan 22 04:29 PM
Dreyer ScottEVP & Chief Commercial OfficerJan 14Sale23.871,32131,53235,716Jan 16 04:12 PM
Fleming Alison BChief Technology OfficerNov 08Option Exercise5.7325,000143,25098,556Nov 13 04:32 PM
Hirsch DavidDirectorNov 08Sale19.3325,000483,25017,117Nov 13 04:33 PM
Fleming Alison BChief Technology OfficerNov 08Sale19.4425,000486,00073,556Nov 13 04:32 PM
Ciaffoni JosephPresident and CEONov 07Option Exercise8.2264,821532,829242,276Nov 08 04:11 PM
Ciaffoni JosephPresident and CEONov 07Sale18.7764,8211,216,774177,455Nov 08 04:11 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.